KraneShares MSCI All China Health Care Index ETF (KURE)
14.78
+0.00 (0.00%)
NYSE · Last Trade: Apr 22nd, 7:28 AM EDT
Detailed Quote
Previous Close | 14.78 |
---|---|
Open | - |
Day's Range | N/A - N/A |
52 Week Range | 12.91 - 20.51 |
Volume | 0 |
Market Cap | 790.73K |
Dividend & Yield | 0.1840 (1.24%) |
1 Month Average Volume | 32,612 |
Chart
News & Press Releases
These ETFs beat the S&P 500 in April 2025’s turbulent market. Learn how TOLZ, VIXY, and KURE can help stabilize your investment strategy.
Via MarketBeat · April 15, 2025
Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.
Via Benzinga · April 11, 2025

China's NPC meeting has sparked optimism in the market, with Chinese stocks and bonds rallying. Investors are hopeful for growth targets but remain skeptical.
Via Benzinga · March 7, 2025
China Stocks Look Set For A Rebound, Morgan Stanley Quant Strategists Saybenzinga.com
Investors in mainland China are rapidly unwinding their stock-index hedges, in an indication that a possible end to Chengdu’s lockdown and policies to stabilize the yuan will lead to a near-term market rally, reported
Via Benzinga · September 13, 2022